SK12542003A3 - Farmaceutická kompozícia obsahujúca 3,7-diazabicyklo-[3.3.1]- deriváty a jej použitie - Google Patents

Farmaceutická kompozícia obsahujúca 3,7-diazabicyklo-[3.3.1]- deriváty a jej použitie Download PDF

Info

Publication number
SK12542003A3
SK12542003A3 SK1254-2003A SK12542003A SK12542003A3 SK 12542003 A3 SK12542003 A3 SK 12542003A3 SK 12542003 A SK12542003 A SK 12542003A SK 12542003 A3 SK12542003 A3 SK 12542003A3
Authority
SK
Slovakia
Prior art keywords
composition
diazabicyclo
oxa
composition according
butyl
Prior art date
Application number
SK1254-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Hans Carlsson
Anette Larsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0101326A external-priority patent/SE0101326D0/xx
Priority claimed from SE0101325A external-priority patent/SE0101325D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SK12542003A3 publication Critical patent/SK12542003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK1254-2003A 2001-04-12 2002-04-12 Farmaceutická kompozícia obsahujúca 3,7-diazabicyklo-[3.3.1]- deriváty a jej použitie SK12542003A3 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0101326A SE0101326D0 (sv) 2001-04-12 2001-04-12 Pharmaceutical formulation
SE0101325A SE0101325D0 (sv) 2001-04-12 2001-04-12 Pharmaceutical formulation
PCT/SE2002/000724 WO2002083687A1 (en) 2001-04-12 2002-04-12 3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds

Publications (1)

Publication Number Publication Date
SK12542003A3 true SK12542003A3 (sk) 2004-03-02

Family

ID=26655442

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1254-2003A SK12542003A3 (sk) 2001-04-12 2002-04-12 Farmaceutická kompozícia obsahujúca 3,7-diazabicyklo-[3.3.1]- deriváty a jej použitie

Country Status (23)

Country Link
US (1) US20040132798A1 (cs)
EP (1) EP1389211A1 (cs)
JP (1) JP2004525969A (cs)
KR (1) KR20040005917A (cs)
CN (1) CN1279916C (cs)
AR (1) AR035807A1 (cs)
BG (1) BG108235A (cs)
BR (1) BR0208830A (cs)
CA (1) CA2443464A1 (cs)
CZ (1) CZ20032759A3 (cs)
EE (1) EE200300506A (cs)
HU (1) HUP0303481A3 (cs)
IL (1) IL158035A0 (cs)
IS (1) IS6990A (cs)
MX (1) MXPA03009213A (cs)
MY (1) MY141595A (cs)
NO (1) NO20034528L (cs)
NZ (1) NZ528559A (cs)
PL (1) PL367182A1 (cs)
RU (1) RU2003129229A (cs)
SK (1) SK12542003A3 (cs)
TW (1) TWI259836B (cs)
WO (1) WO2002083687A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
KR20070100820A (ko) 2005-01-31 2007-10-11 가부시키가이샤 바이오세렌택 경피 흡수 제제, 경피 흡수 제제 유지 시트 및 경피 흡수제제 유지 용구
KR20080021114A (ko) 2005-06-13 2008-03-06 아스트라제네카 아베 심부정맥의 치료를 위한 신규한 옥사비스피딘 화합물
TW200940110A (en) * 2008-02-22 2009-10-01 Astrazeneca Ab Pharmaceutical formulation comprising oxabispidines
US10702485B2 (en) * 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
DE4402933A1 (de) * 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
TR200102911T2 (tr) * 1999-04-09 2002-01-21 Astrazeneca Ab Adamantan türevleri.
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
SE0101329D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab Pharmaceutical formulation
SE0101327D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New crystalline forms

Also Published As

Publication number Publication date
BR0208830A (pt) 2004-03-09
BG108235A (bg) 2005-04-30
NZ528559A (en) 2005-03-24
US20040132798A1 (en) 2004-07-08
CN1514838A (zh) 2004-07-21
EE200300506A (et) 2004-02-16
JP2004525969A (ja) 2004-08-26
TWI259836B (en) 2006-08-11
IL158035A0 (en) 2004-03-28
IS6990A (is) 2003-10-10
NO20034528L (no) 2003-12-08
MY141595A (en) 2010-05-14
WO2002083687A1 (en) 2002-10-24
CN1279916C (zh) 2006-10-18
CA2443464A1 (en) 2002-10-24
KR20040005917A (ko) 2004-01-16
RU2003129229A (ru) 2005-04-10
EP1389211A1 (en) 2004-02-18
MXPA03009213A (es) 2004-01-29
HUP0303481A3 (en) 2005-04-28
PL367182A1 (en) 2005-02-21
AR035807A1 (es) 2004-07-14
NO20034528D0 (no) 2003-10-09
HUP0303481A2 (hu) 2004-01-28
CZ20032759A3 (cs) 2004-01-14

Similar Documents

Publication Publication Date Title
CN101001629B (zh) 药物组合物
US7202236B2 (en) Modified release pharmaceutical formulation
US11820772B2 (en) Polymorphs of the hydrochloride salt of linaprazan glurate
SK15912003A3 (sk) Farmaceutická formulácia obsahujúca iota-karagenan a spôsob jej prípravy
CZ20032760A3 (cs) Farmaceutická kompozice obsahující 3,7-diazabicyklo[3.3.1]-deriváty jako účinnou složku a její použití
US8771733B2 (en) Pharmaceutical composition containing an anti-nucleating agent
CN115813923A (zh) 用于治疗神经性起立性低血压的化合物
US7781424B2 (en) Modified release pharmaceutical formulation
CZ20032759A3 (cs) Farmaceutická kompozice obsahující 3,7-diazabicyklo[3.3.1]-deriváty jako účinnou složkou a její použití
CN117616022A (zh) 晶形
EP1389212B1 (en) 3,7-diazabicyclo 3.3.1| formulations as anti-arrythmic compounds
JP2018515566A (ja) 医薬組成物
RU2767872C2 (ru) Фармацевтическая композиция и способ ее получения
CN120769846A (zh) 抗纤维化化合物的固体形式、盐和多晶型物
CN116940346A (zh) 固体分散体
AU2002253749A1 (en) 3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds
ZA200307757B (en) 3,7-Diazabicyclo[3.3.1]formulations as antiarrhythmic compounds.
CN120641082A (zh) 包含7-(4-氯苄基)-1-(3-羟基丙基)-3-甲基-8-(3-(三氟甲氧基)-苯氧基)-3,7-二氢-1h-嘌呤-2,6-二酮的药物组合物
WO2022253261A1 (zh) Lazertinib甲磺酸盐的水合物晶型及其制备方法和用途
CN115487186A (zh) 一种具有mTOR抑制活性的药物制剂及其制备方法
AU2002253750A1 (en) 3,7-diazabicyclo [3.3.1] formulations as anti-arrythmic compounds

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure